26,072 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Hamilton Lane Advisors LLC

Hamilton Lane Advisors LLC acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 26,072 shares of the company's stock, valued at approximately $1,392,000. Doximity makes up approximately 1.3% of Hamilton Lane Advisors LLC's holdings, making the stock its 10th largest position.

A number of other large investors have also modified their holdings of DOCS. FMR LLC grew its stake in Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company's stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the period. Lord Abbett & CO. LLC purchased a new position in Doximity during the third quarter valued at $29,453,000. Los Angeles Capital Management LLC grew its position in shares of Doximity by 6,242.6% in the third quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company's stock valued at $28,359,000 after purchasing an additional 640,612 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of Doximity during the third quarter worth about $24,691,000. Finally, Geode Capital Management LLC raised its position in shares of Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock worth $124,503,000 after purchasing an additional 472,565 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Analyst Ratings Changes

DOCS has been the topic of several research analyst reports. JPMorgan Chase & Co. lifted their price objective on Doximity from $30.00 to $48.00 and gave the stock a "neutral" rating in a report on Thursday, November 21st. Canaccord Genuity Group reaffirmed a "hold" rating and issued a $60.00 price target (up from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Barclays raised their price objective on Doximity from $52.00 to $75.00 and gave the company an "overweight" rating in a report on Monday, November 11th. Wells Fargo & Company upped their target price on shares of Doximity from $41.00 to $43.00 and gave the stock an "equal weight" rating in a report on Monday. Finally, Truist Financial increased their target price on shares of Doximity from $35.00 to $49.00 and gave the company a "hold" rating in a research report on Thursday, November 14th. Thirteen investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Doximity has an average rating of "Hold" and an average price target of $53.12.

Doximity Stock Up 0.4 %

NASDAQ:DOCS traded up $0.23 on Thursday, reaching $53.20. The company's stock had a trading volume of 672,704 shares, compared to its average volume of 1,480,900. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75. The stock has a 50 day moving average price of $53.61 and a 200 day moving average price of $42.17. The firm has a market cap of $9.93 billion, a price-to-earnings ratio of 61.15, a price-to-earnings-growth ratio of 4.12 and a beta of 1.38.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.